overview of the management of her2-low breast cancer patients
Published 1 year ago • 156 plays • Length 7:13Download video MP4
Download video MP3
Similar videos
-
2:30
prognostic value of her2-low status in breast cancer: a systematic review and meta-analysis
-
5:16
treatment options for her2-low breast cancer: all you need to know
-
0:56
remaining questions on the management of her2-low breast cancer
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
11:25
podcast 293: her2-“low” breast cancer and its reponse to an antibody-drug conjugate
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
11:12
her2-low breast cancer: destiny or good science?
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
51:38
medical update: her2-positive and triple-positive metastatic breast cancer
-
30:27
advances in her2-positive and her2-low breast cancer
-
6:46
updates on her2-low breast cancer
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
4:01
management of her2 positive metastatic breast cancer treatment algorithm
-
1:45
the comprehensive genomic characterization of her2-low breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
2:21
adcs for the treatment of her2-low breast cancer
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
2:02
her2-low breast cancer: the esmo expert consensus statements
-
1:10
the evolution of her2-low-positive breast cancer as a clinical subtype
-
0:45
the evolution of her2-low breast cancer from primary to recurrence